Shiramoto, M., Yoshihara, T., Schmider, W., Takagi, H., Nowotny, I., Kajiwara, M., & Muto, H. (2021). Pharmacokinetic and pharmacodynamic similarity between SAR341402 insulin aspart and Japan-approved NovoRapid in healthy Japanese subjects. Nature Portfolio.
Cita Chicago Style (17a ed.)Shiramoto, Masanari, Tatsuya Yoshihara, Wolfgang Schmider, Hiroki Takagi, Irene Nowotny, Miyuki Kajiwara, y Hideya Muto. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.
Cita MLA (8a ed.)Shiramoto, Masanari, et al. Pharmacokinetic and Pharmacodynamic Similarity Between SAR341402 Insulin Aspart and Japan-approved NovoRapid in Healthy Japanese Subjects. Nature Portfolio, 2021.